FCX
44
4
SBUX
29
-2
HAS
29
3
JCI
44
7
MSI
52
3
AES
47
4
AKAM
50
2
KMI
69
8
WM
53
2
LEN
21
3
ADBE
50
3
AON
25
4
URBN
67
3
BIIB
36
8
UNH
42
6
LUV
45
3
ES
12
3
ROK
46
3
NTRS
35
10
SIG
52
5
FCX
44
4
SBUX
29
-2
HAS
29
3
JCI
44
7
MSI
52
3
AES
47
4
AKAM
50
2
KMI
69
8
WM
53
2
LEN
21
3
ADBE
50
3
AON
25
4
URBN
67
3
BIIB
36
8
UNH
42
6
LUV
45
3
ES
12
3
ROK
46
3
NTRS
35
10
SIG
52
5
Financhill
Back

ProPhase Labs Vs. OncoCyte Industry Stock Comparison

Sell
10

PRPH
ProPhase Labs

Last Price:
$0.63
Seasonality Move:
15.03%
Sell
21

OCX
OncoCyte

Last Price:
$2.23
Seasonality Move:
11.63%
Sell
10
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.61. The Score for PRPH is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
21
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.21. The Score for OCX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 24.33 Sell
Chaikin Money Flow: -319202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.77) Sell
Bollinger Bands (100): (1.12 - 2.76) Sell

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.62 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.28 - 2.6) Sell
Bollinger Bands (100): (2.6 - 3.18) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.71 Sell
50-day SMA: 1.34 Sell
200-day SMA: 3.4 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.77 Sell
50-day EMA: 1.23 Sell
200-day EMA: 2.93 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.27 Sell
20-day SMA: 2.39 Sell
50-day SMA: 2.73 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.27 Sell
20-day EMA: 2.4 Sell
50-day EMA: 2.63 Sell
200-day EMA: 3.06 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):